rabeprazole has been researched along with Aging in 1 studies
Rabeprazole: A 4-(3-methoxypropoxy)-3-methylpyridinyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
Aging: The gradual irreversible changes in structure and function of an organism that occur as a result of the passage of time.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The substance has an absolute bioavailability upon oral administration of approximately 52% which is robust against food intake or administration of antacids." | 2.41 | Rabeprazole: pharmacokinetics and pharmacokinetic drug interactions. ( Fuhr, U; Jetter, A, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fuhr, U | 1 |
| Jetter, A | 1 |
1 review available for rabeprazole and Aging
| Article | Year |
|---|---|
Rabeprazole: pharmacokinetics and pharmacokinetic drug interactions.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aging; Anti-Ulcer Agents; Benzimidazoles; Biological | 2002 |